News

FORT LAUDERDALE, Fla. — Rare cases of occlusive retinal vasculitis have occurred with intravitreal therapies, and fluorescein angiography is an important tool to identify and diagnose the ...
"As of the end of August 2023, with 1.5 million vials dosed globally, the estimated reporting rate of retinal vasculitis with occlusion is 0.06/10,000 injections (for retinal vasculitis with or ...
The American Society of Retina Specialists (ASRS) has received reports of at least six cases of occlusive retinal vasculitis following injection of pegcetacoplan (Syfovre) into the eye. In an ...
Regeneron Pharmaceuticals is spearheading a study titled ‘Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept 2 mg: A US Real-World Evidence Study Using the IRIS Registry.’ ...
Key takeaways: A literature search identified 70 eyes with retinal vasculitis or vascular occlusion following brolucizumab for wet age-related macular degeneration. Twenty of 42 eyes experienced ...
The rate of intraocular inflammation in the studies was 0.26%. He said the rate of retinal vasculitis, as estimated from 60,000 total injections, is "on the order of 1:10,000, or 0.1%." Push Back ...
Meeting Coverage > ASRS Pegcetacoplan-Related Eye Inflammation: The Search Is on for Answers — More than a half dozen reports in the last month point to no clear etiology by Charles Bankhead ...
Experts flag eye inflammation reports tied to Apellis' geographic atrophy med Syfovre By Zoey Becker Jul 17, 2023 5:30pm Apellis Pharmaceuticals side effects inflammation safety profile ...